key: cord-0683987-2l1nuasc
authors: van de Ven, Koen; van Dijken, Harry; Wijsman, Lisa; Gomersbach, Angéla; Schouten, Tanja; Kool, Jolanda; Lenz, Stefanie; Roholl, Paul; Meijer, Adam; van Kasteren, Puck; de Jonge, Jørgen
title: Pathology and immunity after SARS-CoV-2 infection in male ferrets is affected by age and inoculation route
date: 2021-06-30
journal: bioRxiv
DOI: 10.1101/2021.06.30.450298
sha: df7084c15542f1890c6132f8bd29ae956b44dc99
doc_id: 683987
cord_uid: 2l1nuasc

Improving COVID-19 intervention strategies partly relies on animal models to study SARS-CoV-2 disease and immunity. In our pursuit to establish a model for severe COVID-19, we inoculated young and adult male ferrets intranasally or intratracheally with SARS-CoV-2. Intranasal inoculation established an infection in all ferrets, with viral dissemination into the brain and gut. Upon intratracheal inoculation only adult ferrets became infected. However, neither inoculation route induced observable COVID-19 symptoms. Despite this, a persistent inflammation in the nose was prominent in especially young ferrets and follicular hyperplasia in the bronchi developed 21 days post infection. These effects -if sustained- might resemble long-COVID. Respiratory and systemic cellular responses and antibody responses were induced only in animals with an established infection. We conclude that intranasally-infected ferrets resemble asymptomatic COVID-19 and possibly aspects of long-COVID. Combined with the increasing portfolio to measure adaptive immunity, ferrets are a relevant model for SARS-CoV-2 vaccine research.

CoV-2 replication in the LRT was not due to reduced expression of ACE2 or TMPRSS2 (Fig. 2f) . Adult 122 animals did seem to express lower levels of ACE2 and TMPRSS2, but this did not negatively impact 123 viral load (Fig. 2a, b) . 124 125 Pathology in the URT is higher for i.n. infected animals 126

Despite active SARS-CoV-2 replication, ferrets did not display any overt clinical signs of disease. 127

Compared to mock-infected animals, SARS-CoV-2-infected animals did not lose more weight and did 128 not experience fever (Supplemental Fig. 2ab ), nor were alterations in respiratory function and 129 physical activity observed. Despite the absence of clinical disease, infection with SARS-CoV-2 did 130 result in pathological aberrations in the respiratory tract. 131 132

In the nasal turbinates, pathological aberrations were restricted to the respiratory epithelial lining of 133 the naso-and maxilloturbinates (Fig. 3a) . The sub-and intraepithelial inflammation resulted in 134 thickened respiratory mucosa and an exudate of polymorphonuclear cells, lymphocytes and some 135 macrophages. Damage to the epithelial lining was characterized by hypertrophy, hyperplasia, and 136 squamous metaplasia and sporadically the epithelium was absent. Hypertrophy of goblet cells was 137 also present and haemorrhage was sometimes observed. The different pathological facets were 138 categorized into inflammation and damage, for which an end-score was determined as previously 139 described (Fig. 3b , c and Supplemental fig. 3 ) 39 . 140 141

In general, the severity of pathology was dependent on age and infection route, although the age-142 correlation was opposite to our expectations. In the acute phase (5 dpi), i.n. inoculated ferrets 143 displayed more pathological aberrations in the nasal turbinates, which partly resolved by 14 dpi (Fig.  144 3b, c). Strikingly, inflammation and to a lesser extent epithelial damage increased again by 21 dpi in 145 young animals, but was less pronounced in adult ferrets. Notably, this effect was stronger in i.t. 146 infected young ferrets than in i.n. infected young ferrets and involved 100% of the epithelium of the 147 naso-en maxilloturbinates (Fig. 3d) . Pathology in the nose thus increased in young animals even 148 after the infection had been cleared. 149 150

Pathology in the LRT is not affected by inoculation route 151

On a macroscopic level, the lungs of SARS-CoV-2 infected ferrets did not show aberrations in the 152 acute phase (5 dpi), apart from a few darker patches. However, red opalescent coloring along the 153 bronchus and as isolated patches started to appear at 14 and 21 dpi. During the course of this study, 154 there was no increase in lung weight, indicating absence of serious edema (Supplemental Fig. 2c ). 155 Microscopically, slight peribronchi(oli)tis -characterized by the presence of infiltrating cells in the 156 sub-mucosa along the bronchi -was observed 5 dpi (Fig. 4a) . The bronchus epithelium showed some 157 reaction in the form of mild to minor hyperplasia, sometimes visible as repeated epithelial bumps. 158 Strikingly, hyperplasia of the Bronchus-Associated Lymphoid Tissue (BALT) developed in 1 out of 3 159 i.n. and in 2 out of 3 i.t. infected young ferrets by 21 dpi, but was absent in adult ferrets. Mild to 160 strong follicular hyperplasia was located at the first branches of the bronchus and in the more severe 161 cases extended to the smaller bronchiole (Fig. 4a) . Obstruction of bronchioli occurred regularly due 162 to compression by the hyperplastic follicles. These consisted of activated lymphocytes, which 163 penetrated through the muscle layer of the bronch(iol)us into the lamina propria. In addition, albeit 164 low in number, local patches of mild to moderate desquamative interstitial pneumonia had 165 developed. The pathology score and percentage affected lung parenchyma increased from 5 to 21 166 dpi, mostly in in the young ferrets (Fig. 4b-c and Supplemental Fig. 4 ). Of note, young animals that 167

were investigated 21 dpi had tested positive for antibodies against NL-63 and enteric and systemic 168 corona viruses prior to SARS-CoV-2 infection (Supplemental table 1 ). This combination was absent in 169 adult ferrets, complicating the interpretation of these results. 170 171

In concordance with our findings in the lung and nose, pathology in the trachea increased by 21 dpi 172 (Fig. 4d, Supplemental Fig. 5 ). The epithelium of the trachea in all young ferrets and in the i.t. adult 173 group was often hyperplastic and sometimes showed serious damage and pseudo squamous 174 characteristics 21 dpi (Fig. 4e) . Inflammatory cells infiltrated the submucosa and epithelium, most 175 prominently in young ferrets. Since SARS-CoV-2 viral RNA was also detected in the gut, 176 histopathological analysis of the ileum and colon was performed, but no deviations were observed. 177

In conclusion, independent of inoculation route, young animals displayed more severe pathology 178 than adult ferrets in both the URT and LRT, but it is uncertain whether the increase until 21 dpi is 179 due to age or prior exposure to other coronaviruses. 180 181 Cellular and humoral Immunity 182

As several ferrets used in this study displayed antibody responses against ferret corona viruses and 183 NL-63 prior to the start of the study (Supplemental table 1), we wondered if cross-reactive responses  184 to SARS-CoV-2 were present in these animals. We measured antibody responses against SARS-CoV-2 185 spike protein (S) and its receptor binding domain (RBD) by ELISA. Cellar responses were measured by 186

IFNγ-ELISpot in which PBMCs were stimulated with live SARS-CoV-2 or overlapping peptide pools of 187 the S, membrane (M) and nucleoprotein (N) proteins. In five animals the antibody response against 188 SARS-CoV-2 was just above background prior to infection (Supplemental Fig. 6a ). Additionally, 189

another animal in the young i.n. infected group clearly responded against an overlapping peptide 190 pool of SARS-CoV-2 spike protein in ELISpot on two separate time-points before infection 191 (Supplemental Fig. 6b ). This animal tested positive for antibodies against ferret corona and NL63, but 192 not against SARS-CoV-2 (Supplemental table 1 and RBD with no evident differences between young and adult animals 14 dpi (Fig. 5a ). In contrast, 199 antibody titers in i.t. infected animals were lower with a clear distinction between ages. More adult 200

(4/5) than young (1/6) i.t. inoculated ferrets displayed responses against S-protein after infection. 201

Similar findings were obtained for humoral responses against RBD. 202 203

Next, we investigated cellular responses at 14 dpi. PBMCs mainly responded against the larger 204 peptide pools of S (S1 & S2), M and N (Fig. 5b) . We additionally measured responses against 205 envelope (E) and accessory proteins (ORF3a-ORF10), but responses against these peptide pools were 206 marginal and did not differ from naïve animals. Consistent with the low viral load, only 1/6 young i.t. 207

infected animals responded to any SARS-CoV-2 stimulus, indicating that almost no cellular immunity 208 was established in this group by 14 dpi. For the other groups, no clear differences between infection 209 routes or age were observed. The responses 21 dpi were similar to those of 14 dpi (Supplemental 210 Fig. 7a ). As others have reported the presence of cross-reactive T cell responses in humans 40-43 , we 211 also tested if PBMCs from SARS-CoV-2 infected ferrets would respond upon stimulation with spike 212 peptide pools of coronaviruses NL63, OC43, 229E and HKU1. Some animals displayed minor 213 responses, although they were only slightly higher than mock-infected animals (Fig. 5c ). 214 215 We additionally investigated cellular responses in the lung. To reduce contamination of the lung 216 lymphocytes with circulating lymphocytes, lungs were perfused with saline on 14 and 21 dpi. In 217 comparison to PBMCs, responses against the smaller SARS-CoV-2 peptide pools seemed more 218 prominent in lung-derived lymphocytes of young i.n. infected animals. In this group, two out of three 219 ferrets showed responses against ORF3a, ORF6, ORF8, ORF9b and ORF10 peptide pools at 21 dpi 220 (Fig. 5d) . Like in PBMC, cellular responses were absent in the lung of i.t. infected young ferrets. Of 221 note, responses in the lungs of i.t. infected old animals differed between day 14 and 21 post 222 infection, with responses being higher overall on 21 dpi ( Fig. 5d and Supplemental Fig. 7b ). However, 223 the group size (n = 2-3) was too small for reliable statistical testing. 224

In this study we utilized a male ferret model to assess the influence of age and infection route on 226 SARS-CoV-2 disease and immunity. Intranasal inoculation was more efficient in establishing an 227 infection compared to intratracheal administration. This was especially the case for young ferrets, in 228 which virus hardly replicated after i.t. inoculation. In contrast, disease and pathology were not 229 increased in older animals or upon intratracheal inoculation. 230 231

Despite a productive SARS-CoV-2 infection, ferrets did not develop the symptomatic disease that is 232

reported for humans (reviewed in 16 ). A slightly more watery defecation was observed in some 233 animals towards the end of the study, but occurrences were too few to confidently attribute this to 234 SARS-CoV-2 infection. We did however detect SARS-CoV-2 genomic RNA and subgenomic mRNA in 235 rectal swabs and gut tissues at multiple time-points. Subgenomic SARS- perform an intratracheal infection in female ferrets and found viral RNA in the nasal turbinates and 251

trachea, but not in the lung 30 . In our study, adult male ferrets displayed higher viral titers after i.t. 252

infection compared to young ferrets, indicating that age increases susceptibility to LRT SARS-CoV-2 253

infection in the ferret model. We postulated that the reduced viral replication in the LRT of 254 especially young ferrets might be due to differential expression of the SARS-CoV-2 receptors ACE2 255 and TMPRSS2 1, 38 . However, this does not seem to be the case as ACE2 and TMPRSS2 expression was 256 similar between nasal turbinate and lung tissue and young ferrets actually expressed more ACE2 and 257 TMRPSS2 than adult ferrets. Combined with the observation that we did detect viral infection of the 258 LRT by RT-qPCR for genomic RNA and subgenomic mRNA, it seems that factors other than receptor 259 expression prevent the successful replication of SARS-CoV-2 in the LRT. 260 261

Notwithstanding the lack of clinical symptoms, we and others 30, 32 did find pathological 262 abnormalities in infected ferrets. While SARS-CoV-2 replicated less efficiently in young i.t. inoculated 263 animals and almost no adaptive immune response was induced, they did display some of the most 264 affected pathology. It is however important to mention that all young ferrets euthanized on 21 dpi 265 tested positive for antibodies against ferret corona and NL63 prior to SARS- against the E protein was observed. Cellular responses against multiple accessory proteins of SARS-286

CoV-2 were limited in the blood, but lung-derived lymphocytes did respond against several of these 287 peptide pools. Likely, the relative abundance of SARS-CoV-2 specific T cells is higher in the lung, 288

thereby increasing the sensitivity of the ELISpot assay. As cross-reactive cellular responses for SARS-289

CoV-2 have been described in humans 40-43 , we also measured responses in the blood against peptide 290 pools of S-proteins of other corona viruses. However, responses were low and interpretation of the 291 results will require a larger group size and more sensitive assays. 292 293

Due to the global circumstances at the time of this study, there are several caveats present in the 294 experimental set-up. The availability of (male) ferrets was limited and hence we could not 295

investigate all groups at every timepoint. In addition, several ferrets were previously exposed to 296

Aleutian disease and coronaviruses other than SARS-CoV-2 (details in Supplemental data). Although 297

we did not find evidence that this infection history influenced our results, we cannot fully exclude 298 that possibility. Finally, due to the limited availability of animals it will be difficult to model SARS-299

CoV-2 infections in older ferrets. However, as we did not find strong differences between young and 300 adult ferrets upon intranasal inoculation, the use of young ferrets should suffice for future 301 experiments. 302 303

As has been discussed here, ferrets are readily infected with SARS- Sample collection 382

During the experiment, blood was collected from the vena cava and stored in either sodium-heparin 383 coated VACUETTE tubes (Greiner) for cellular assays or in CAT serum separator clot activator 384 VACUETTE tubes (Greiner) to isolate serum. Blood was kept at RT and analyzed the same day. At the 385 end of the experiment, blood was collected by heart puncture after which groups B and C received a 386 lung perfusion to remove the majority of lymphocytes in the circulation that might affect cellular 387 assays. The lower 4cm of the trachea was stored in formalin to study pathology while the middle 388

1.5cm was used to determine viral load. Lungs were weighed and the left cranial lobe was inflated 389

with formalin and stored in 10% buffered formalin for histopathological analysis. To assess viral RNA 390

and TCID 50-titers, 0.5cm slices of the right cranial, middle and caudal lobe were collected in Lysing 391

Matrix A tubes (MP Biomedicals, Germany). Samples in Lysing Matrix A tubes were stored at -80°C 392 until analysis. The rest of the lungs were used for immunological analysis and were kept cold (4°C) 393 o/n until processing the next day. 394 395

Of the intestine, 1.5cm parts of the ileum and upper colon were collected in Lysing Matrix A tubes 396 and formalin to assess viral RNA and pathology respectively. Next, the cranium was bisected with an 397 oscillating blade moving from the caudal to the rostral position to prevent contamination of brain 398 tissue by any particles from URT. The nasal turbinates on the left of the septum were used for 399 pathology while the right side was used for virology and immunology. Finally, the olfactory bulb (OB) 400

and sections of the cerebrum and cerebellum were collected for virology and pathology. scored on a scale of 0 (no aberrations) to 5 (severe damage) and were summarized in two 'end 438 scores' for the categories 'epithelial damage' and 'inflammation'. Microscopic slides were 439 randomized and scored blindly by an experienced pathologist. 440 441

Lymphocyte isolation 442

Blood collected in sodium-heparin tubes was diluted 1:1 with PBS (Gibco) and layered on top of a 1:1 443 mixture of Lymphoprep (1.077 g/ml, Stemcell) and Lymphoyte-M (1.0875 g/ml, Cedarlane). The 444 gradient was spun at 800x g for 30 minutes and the interface containing PBMCs was collected. The 445

cells were subsequently washed twice with washing medium (RPMI1640 + 1% FBS) and spun down 446 at 500x g for 10 minutes (first wash) or 5 minutes (second wash). After the final washing step, cells 447

were resuspended in stimulation medium (RPMI1640 + 10% FBS + 1x penicillin-streptomycin-448 glutamine). 449 450

On days 14 and 21 after infection, the lungs of euthanized animals were perfused with saline to 451 remove circulating lymphocytes from the lungs as described before 56 . Lymphocytes from the lung 452

were isolated using enzymatic digestion. Lungs were first processed into small dices of 453 approximately 5mm 3 using scissors. The diced tissue was then digested for 60 minutes at 37°C in 454

12ml of a pre-heated suspension of collagenase I (2.4mg/ml, Merck) and DNase I (1mg/ml, Novus 455 Biologicals) in RPMI1640 while rotating. Tissue was further homogenized by gently pressing the 456 tissue over a sieve using the plunger of a 10ml syringe. The resulting suspension was diluted with 457 EDTA-supplemented washing medium (RPMI1640 + 1% FBS + 2mM EDTA (Invitrogen)) and filtered 458 over a 70μm cell strainer. This suspension was layered on top of 15ml Lympholyte-M in a 50ml tube. 459

Density centrifugation and washing steps were performed as described above, with the exception 460 that washing medium was supplemented with EDTA to prevent agglutination of cells Transcription PCR (RT-qPCR) reaction contained 5µl of sample nucleic acid, 7µl of 4x Taqman Fast  507 Virus Master Mix (Thermo Fisher), 5µl of DNAse/RNAse free water and 3µl of primers and probe mix 508 (sequences shown in Table 1 ). The in-house SARS-CoV-2 detection assay was performed using E-509 gene primers and probe specific for SARS-related betacoronaviruses as described by Corman Total nucleic acid extracted with the MagNA Pure 96 system was used to determine ACE2 and 518 TMPRSS2 expression in a separate reaction. First, cDNA was synthesized from the isolated RNA with 519 the iScript TM cDNA synthesis kit (Bio-Rad) according to the manufacturers protocol using a 520

StepOnePlus RT-PCR system (Thermo Fisher China) and washed thrice with PBS + 0.1% Tween-80 before use. Sera were first diluted 1:100 in PBS 542 + 0.1% Tween-80 and then 2-fold serially diluted. Per well, 100μl of diluted sera was added and 543 plates were incubated for 60 minutes at 37°C. After washing thrice with 0.1% Tween-80, plates were 544 incubated for 60 minutes at 37°C with HRP-conjugated goat anti-ferret IgG (Alpha Diagnostic), 545 diluted 1:5000 in PBS containing 0.1% Tween-80 and 0.5% Protivar (Nutricia). Plates were then 546 washed trice with PBS + 0.1% Tween-80 and once with PBS, followed by development with 100μl 547

SureBlue™ TMB (KPL) substrate. Development was stopped after 10 minutes by addition of 100μl 548 2M H2SO4 and OD450-values were determined on the EL808 absorbance reader (Bio-Tek 549

Instruments). Individual curves were visualized using local polynomial regression fitting with R 550 software 65 . Antibody titers were determined as the dilution at which antibody responses dropped 551 below background. This background was calculated as the 'mean + 3 * standard deviation' of the 552 OD450 at a 400x serum-dilution of all animals tested before SARS-CoV-2 infection. 553 554

Data analysis & Statistics 555

All raw data was analyzed with the software detailed above. These data were then exported to Excel 556 and loaded into R software 65 . Data analysis and visualization of data was carried out using the R 557 packages ggplot2 66 , tidyverse 67 , ggpubr 68 . Due to the exploratory goal and small group 558 numbers of this study, statistical analysis was limited. Blood cell counts in young and adult animals 559 was compared in R using the Wilcoxon signed-rank test and corrected for multiple testing by the 560

Holm-Bonferroni method 69 . 561 562

Data availability 563

All raw data files are being stored in-house on backed-up servers and are available upon reasonable 564 request to the corresponding author. The sequence of the SARS-CoV-2 isolate can be found on 565 GISAID (accession ID: EPI_ISL_454753). 566

A pneumonia outbreak associated with a new coronavirus of probable bat 568 origin

SARS-CoV-2 Vaccines

Will SARS-CoV-2 variants of concern affect the promise of vaccines? Nat Rev 571 Immunol

Animal models for COVID-19

Animal models for SARS-CoV-2

Transmission of SARS-CoV-2: implications for infection prevention precautions

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

Aerosol transmission of SARS-CoV-2? Evidence, prevention and control

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 584 in Zhejiang province, China

Virological assessment of hospitalized patients with COVID-2019

Potential fecal transmission of SARS-CoV-2: Current evidence and implications 589 for public health

Viral presence and immunopathology in patients with lethal COVID-19: a 591 prospective autopsy cohort study

Clinical course and risk factors for mortality of adult inpatients with COVID-19 593 in Wuhan, China: a retrospective cohort study

The epidemiology and clinical information about COVID-19

Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective 597 Observational Study

Histopathology and ultrastructural findings of fatal COVID-19 infections in 599 Washington State: a case series

The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus 601 Diseases (COVID-19) -China

Case characteristics, resource use, and outcomes of 10 021 patients 603 with COVID-19 admitted to 920 German hospitals: an observational study. The Lancet 604 Respiratory Medicine

Estimates of the severity of coronavirus disease 2019: a model-based analysis. 606 The Lancet Infectious Diseases

Post-acute COVID-19 syndrome

The ferret as a model organism to study influenza A virus 609 infection

Animal models for the preclinical evaluation of 611 candidate influenza vaccines

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short-and 615 long-term models

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in 617 Ferrets

SARS-CoV-2 is transmitted via contact and via the air between ferrets

SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental 621 transmission study

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-623 coronavirus 2

A single dose of an adenovirus-vectored vaccine provides protection against 625 SARS-CoV-2 challenge

Dose-dependent response to infection with SARS-CoV-2 in the ferret model 627 and evidence of protective immunity

Low pathogenic avian influenza A(H7N9) virus causes high mortality in 629 ferrets upon intratracheal challenge: a model to study intervention strategies

H7N9 Live attenuated influenza vaccine is highly immunogenic, prevents 632 virus replication and protects against severe bronchopneumonia in ferrets

Pathogenesis of influenza A/H5N1 virus infection in ferrets differs between 635 intranasal and intratracheal routes of inoculation

Lymphocyte subsets and natural killer cell activity in healthy old people and 638 centenarians

The furin cleavage site in the SARS-CoV-2 spike protein is required for 640 transmission in ferrets

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by 642 a Clinically Proven Protease Inhibitor

Development and pre-clinical evaluation of two LAIV strains against 644 potentially pandemic H2N2 influenza virus

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed 648 humans

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and 650 uninfected controls

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with 652 COVID-19 Disease and Unexposed Individuals

Histopathological findings and viral tropism in UK patients with severe fatal 654 COVID-19: a post-mortem study

SARS-CoV-2 productively infects human gut enterocytes

Fecal-oral transmission of SARS-CoV-2: review of 658 laboratory-confirmed virus in gastrointestinal system

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in 660

Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis

Neuroinvasion of SARS-CoV-2 in human and mouse brain

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous 665 system entry in individuals with COVID-19

Is Cross-Reactive Immunity Triggering COVID-19 667 Immunopathogenesis?

Follow-up study of the pulmonary function and related physiological 669 characteristics of COVID-19 survivors three months after recovery

Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: 672 a prospective, community-based study

Post-covid syndrome in individuals admitted to hospital with covid-19: 674 retrospective cohort study

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK 676 convalescent individuals following COVID-19

A systematic review of asymptomatic infections with COVID-19

Systemic and respiratory T-cells 680 induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets

Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-683 Mediated Immune Response in Ferrets following Influenza Virus Infection

Influenza vaccination accelerates recovery of ferrets from lymphopenia

Analyses of Cellular Immune 688 Responses in Ferrets Following Influenza Virus Infection

Characterization of antibodies against ferret immunoglobulins, 691 cytokines and CD markers

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Diagnosis of human metapneumovirus 696 and rhinovirus in patients with respiratory tract infections by an internally controlled 697 multiplex real-time RNA PCR

In vivo structure and dynamics of the RNA genome of SARS-Cov-2. bioRxiv

Molecular characterization of in vivo adjuvant activity in ferrets vaccinated 701 against influenza virus

R: A Language and Environment for Statistical Computing

Elegant Graphics for Data Analysis

Welcome to the Tidyverse

ggpubr: 'ggplot2' Based Publication Ready Plots

A Simple Sequentially Rejective Multiple Test Procedure

We would like to thank Gabriel Goderski for isolating and growing the initial SARS-CoV-2 isolate and 712

We are also grateful to the biotechnicians from the animal facility for 713 excellent care-taking of the animals and dr. Luytjes for critical reviewing of the manuscript

717 analyzed data. K.v.d.V. and J.d.J. designed the experiment and wrote the manuscript together with 718

Correspondence and requests for materials should be addressed to

A) Young and adult ferrets were 728 inoculated intranasally or intratracheally with 10 7 TCID50 SARS-CoV-2 on day 0. On 5, 14 and 21 days post 729 infection (dpi), 3 ferrets were euthanized per group

No intranasally inoculated adult ferrets were euthanized at 14 dpi due to limited availability 731 of adult ferrets. B) Cell counts in blood of uninfected young and adult ferrets. N = 15 for young animals and n = 732 11 for adult animals. Boxplots depict the median with the first and third quartiles. Differences between young 733 and adult ferrets were tested via a two-sample Wilcoxon test and corrected for multiple testing using the Holm

B) Viral load measured by RT-qPCR 739 (a) and TCID50-assay (b) in swabs collected from SARS-CoV-2 infected ferrets on various days post infection 740 (dpi). C) Viral RNA in tissues at 5, 14 and 21 dpi measured by RT-qPCR. D) Total viral RNA on 5 dpi as depicted 741 in (c) plotted against subgenomic viral RNA. E) Infectious virus detected by TCID50-assay in nasal turbinates and 742 lung 5 dpi. F) Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 protease in nasal turbinate and lung 743 tissue of placebo animals, plotted as arbitrary units (AU)

Representative 751 haematoxylin and eosin stained sections of normal, moderate (score 2) and severe (score 4) affected naso-and 752 maxilloturbinates at 100x magnification. SARS-CoV-2 infection induced infiltration of polymorphonuclear cells 753 into the lamina propria and submucosa of the respiratory epithelium, resulting in thickened respiratory 754 mucosa (indicated with '1'). This was accompanied by exudate containing mucus (moderate) and many 755 polymorphonuclear cells, lymphocytes and some macrophages

Bars 757 represent 50μm. B-D) Scoring by parameters related to epithelial damage (b), inflammation (c) and percentage 758 of tissue involved in pathologic changes (d). The infection-induced pathology was scored on a scale of 0-5 759 based on the parameters described in the materials and methods. With exception of

Representative haematoxylin and eosin stained sections of 765 normal, moderately and severely affected lung tissue (a) at overview, 25x and 100x magnification and trachea 766 (e) at 100x magnification. A) Lungs of SARS-CoV-2

consisting of activated lymphocytes that penetrate through the muscle 768 layer of the bronch(iol)us into the lamina propria and submucosa (indicated in figure with '1'). Hyperplasia of 769 bronchial epithelium visible as repeated bumps (2), cellular infiltrate into the submucosa (3) and exudate in 770 the lumen (4) were also observed. The presence of hyper

The alveolar epithelium (pneumocytes) exhibited 773 squamous-like characteristics. B-D) Pathology was summarized in an overall score ranging from 0-5 based on 774 the parameters described in the materials and methods. Pathology score (b) and % of tissue affected (c) for 775 lung tissue and pathology score for trachea (d). With exception of

damage and pseudo-squamous 777 characteristics of the epithelium (8) and infiltration of inflammatory cells into the submucosa and epithelium 778 of the trachea

Figure 5: Cellular and humoral responses in SARS-CoV-2 infected ferrets are affected by inoculation route. A) 783

Humoral responses detected by ELISA against whole spike (S) and the receptor binding domain (RBD) region of 784 spike in serum 14/15 dpi. Responses are depicted as the (modelled) dilution at which the ELISA curve drops 785 below background (mean + 3x SD of SARS-CoV-2 naïve animals at 200x dilution). The dotted line indicates the 786 lowest dilution tested and negative samples were set to half that dilution for visualization purposes

Cells were 788 stimulated with SARS-CoV-2 peptide pools or live virus. HIV cntrl and Mumps are negative controls for peptide 789 pool and virus stimulations respectively. Data shown here were corrected for medium background and were 790 set to a minimum of 1 spot for visualization on a log-scale. B) PBMCs

PBMCs isolated 14 or 21 dpi were thawed and stimulated with peptide pools of endemic human 792 coronaviruses. D) Responses by lung-derived lymphocytes at 21 dpi. For b, c and d, samples were collected 14, 793 15 or 21 dpi, but visualized as a single group

Plots show the gating strategy for 803 identification of cell subsets in whole blood of young and adult ferrets. CD14 and CD79a subsets were gated in 804 the 'Single cells' population excluding all CD3+ cells

Supplemental figure 2: SARS-CoV-2 infection does not induce clinical disease in male ferrets. A) body weight 810 was measured on various time points and depicted as % of original bodyweight on the day of infection

Body temperature was measured continuously in 30-minute intervals by implanted abdominal transponders

-6 days before infection) from the 813 body temperature after SARS-CoV-2 infection. C) Relative lung weight depicted as a percentage of total body 814 weight on the day of infection. The different panels depict the relative lung weight on 5, 14 and 21 days post 815 infection (dpi)

Scoring of (a) olfactory and (b) 821 respiratory turbinates. Panels depict individual parameters related to epithelial damage and inflammation on 822 5, 14 and 21 days post infection (dpi). The infection-induced pathology was scored on a scale of 0-5 based on 823 the parameters described in the materials and methods. With exception of

Panels show individual scoring by parameters 829 related to epithelial damage and inflammation. The infection-induced pathology was scored on a scale of 0-5 830 based on the parameters described in the materials and methods on 5

With exception of 'Adult i.t.' on 14 dpi (n = 2), all groups are n = 3

Panels show individual scoring by parameters 836 related to epithelial damage and inflammation. The infection-induced pathology was scored on a scale of 0-5 837 based on the parameters described in the materials and methods on 5

With exception of 'Adult i.t.' on 14 dpi (n = 2), all groups are n = 3

Supplemental figure 6: Pre-existing immune responses against SARS-CoV-2 in ferrets. A) Sera from three 843 animals before SARS-CoV-2 infection contained small antibody responses against (the receptor binding domain 844

RBD] of) spike (S) in ELISA assays, but these were different animals from the one that

(modelled) dilution at which the ELISA curve drops below 846 background (mean + 3x SD of SARS-CoV-2 naïve animals at 200x dilution). The dotted line indicates the lowest 847 dilution tested and negative samples were set to half that dilution for visualization purposes. Positive control 848 consists of sera of SARS-CoV-2 infected animals collected 21 days post infection (dpi). N= 3 for positive control 849 sera and N = 6-9 for other groups B) IFNγ-ELISpots performed with PBMCs

CoV-2 infection indicate that one animal already possessed (cross-reactive) T cell responses against 851 overlapping peptide pools of the S-protein of SARS-CoV-2. Data shown were corrected for medium background 852 and were set to a minimum of 1 spot for visualization on a log-scale

Supplemental figure 7: Cellular responses against SARS-CoV-2 in PBMC and lung. A, B) Cellular responses in 857

PBMCs (a) and lung derived lymphocytes (b) as determined by IFNγ-ELISpot. Cells were stimulated with various 858

Dots show individual ferrets while black lines indicate the group 859 geometric mean. Data were corrected for medium background and were set to a minimum of 1 spot for 860 visualization on a log-scale. A) Responses in PBMC isolated 21 days post infection (dpi). B) Responses of lung-861 derived lymphocytes 14 dpi. N = 3 for all panels